Literature DB >> 20193016

Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin.

Nikolaus Romani1, Björn E Clausen, Patrizia Stoitzner.   

Abstract

Langerhans cells (LCs) are antigen-presenting dendritic cells (DCs) that reside in epithelia. The best studied example is the LC of the epidermis. By electron microscopy, their identifying feature is the unique rod- or tennis racket-shaped Birbeck granule. The phenotypic hallmark is their expression of the C-type lectin receptor langerin/CD207. Langerin, however, is also expressed on a recently discovered population of DC in the dermis and other tissues of the body. These 'dermal langerin(+) dendritic cells' are unrelated to LCs. The complex field of langerin-negative dermal DCs is not dealt with here. In this article, we briefly review the history, ontogeny, and homeostasis of LCs. More emphasis is laid on the discussion of functional properties in vivo. Novel models using genetically engineered mice are contributing tremendously to our understanding of the role of LCs in eliciting adaptive immune responses against pathogens or tumors and in inducing and maintaining tolerance against self antigens and innocuous substances in vivo. Also, innate effector functions are increasingly being recognized. Current activities in this area are reviewed, and possibilities for future exploitation of LC in medicine, e.g. for the improvement of vaccines, are contemplated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20193016      PMCID: PMC2907488          DOI: 10.1111/j.0105-2896.2009.00886.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  216 in total

1.  Maturational steps of bone marrow-derived dendritic murine epidermal cells. Phenotypic and functional studies on Langerhans cells and Thy-1+ dendritic epidermal cells in the perinatal period.

Authors:  A Elbe; E Tschachler; G Steiner; A Binder; K Wolff; G Stingl
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

2.  Ontogeny of Langerhans cells in human embryonic and fetal skin: cell densities and phenotypic expression relative to epidermal growth.

Authors:  C A Foster; K A Holbrook
Journal:  Am J Anat       Date:  1989-02

3.  Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways.

Authors:  P G Holt; S Haining; D J Nelson; J D Sedgwick
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

4.  Distribution of HLA class II molecules in epidermal Langerhans cells in situ.

Authors:  A M Mommaas; A A Mulder; C J Out; G Girolomoni; H K Koerten; B J Vermeer; F Koning
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

5.  Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.

Authors:  S Grabbe; K Steinbrink; M Steinert; T A Luger; T Schwarz
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

6.  Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization.

Authors:  A Lenz; M Heine; G Schuler; N Romani
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Human Langerhans cells express E-cadherin.

Authors:  A Blauvelt; S I Katz; M C Udey
Journal:  J Invest Dermatol       Date:  1995-02       Impact factor: 8.551

8.  Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells.

Authors:  T A Borkowski; A J Nelson; A G Farr; M C Udey
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

9.  Mitotic activities of normal epidermal Langerhans cells.

Authors:  S Miyauchi; K Hashimoto
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

10.  Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.

Authors:  N Romani; S Koide; M Crowley; M Witmer-Pack; A M Livingstone; C G Fathman; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  144 in total

Review 1.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination.

Authors:  Irlanda Olvera-Gomez; Sara E Hamilton; Zhengguo Xiao; Carla P Guimaraes; Hidde L Ploegh; Kristin A Hogquist; Liangchun Wang; Stephen C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Langerhans cells are precommitted to immune tolerance induction.

Authors:  Elena Shklovskaya; Brendan J O'Sullivan; Lai Guan Ng; Ben Roediger; Ranjeny Thomas; Wolfgang Weninger; Barbara Fazekas de St Groth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

4.  Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.

Authors:  Patrizia Stoitzner; Nikolaus Romani
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

5.  Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector.

Authors:  S Top; E Foulon; B Pignolet; M Deplanche; C Caubet; C Tasca; S Bertagnoli; G Meyer; G Foucras
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

Review 7.  In vivo function of Langerhans cells and dermal dendritic cells.

Authors:  Daniel H Kaplan
Journal:  Trends Immunol       Date:  2010-10-28       Impact factor: 16.687

Review 8.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

9.  Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.

Authors:  Michelle Nicole Messmer; Joshua Pasmowitz; Laura Elizabeth Kropp; Simon C Watkins; Robert Julian Binder
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

10.  Jorge Lobo's disease: immunohistochemical characterization of dendritic cells in cutaneous lesions.

Authors:  Tania Cristina Barboza; Juarez Antonio Simões Quaresma; Arival Cardoso de Brito; Marilia Brasil Xavier; Clivia Maria Moraes de Oliveira; Deborah Aben Athar Unger; Maria Irma Seixas Duarte; Mirian Nacagami Sotto; Carla Pagliari
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.